CNC

Centene Corporation (CNC)
Healthcare • Healthcare Plans • $62.22 • MCap: 30,736,369,664 🌐
https://www.centene.com • Centene Corporation operates as a managed care company that provides programs and services to under-insured families, and commercial organizations in the United States. It operates through four segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment offers the temporary assistance for needy families; medicaid expansion; aged, blind, or disabled; and children's health insurance programs, as well as long-term services and supports; foster care; and medicare-medicaid plans. This segment also provides healthcare products and services. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual and commercial group. The Other segment operates clinical healthcare and pharmacies, as well as offers vision and dental, behavioral health, and centralized services. It provides services through primary and specialty care physicians, hospitals, behavioral health practitioners, and ancillary providers. The company was founded in 1984 and is headquartered in Saint Louis, Missouri.
Buy Decision Core
Total Score
35
Business Quality
1
Financial Strength
8
Growth Outlook
1
Momentum
4
Price Action
Current
62.22
52W High
68.72
52W Low
25.21
Above 50DMA
63.62 (-2.19%)
Above 200DMA
46.60 (33.53%)
Relative Strength
Relative Strength
0.6
RS 3M
0.16
RS 6M
0.43
RS 9M
0.87
RS 12M
1.37
Fundamentals
Revenue Growth
0.05%
Earnings Growth
0%
ROE
-0.20%
ROA
0.02%
Valuation
PE (Fwd)
12.05
PEG
1.19
P/B
1.36
Upside
13.58%
Risk
Beta
1.08
Short %
0.03
Risk Score
1.00
Analyst
Rating
buy
Target
70.67
Beta
1.08
Analysts
0


Total Score
35
Upside
13.58%
Relative Strength
0.6
Beta
1.08
Why Buy?
  • Trading above 200 DMA
Key Risks
  • Negative ROE
Score Breakdown
Business
1
Financial
8
Growth
1
Valuation
15
Risk
4
Momentum
4
Technical
52W High: 68.72
52W Low: 25.21
Above 50DMA: -2.19%
Above 200DMA: 33.53%
Valuation
Forward PE: 12.05
PEG: 1.19
P/B: 1.36
Upside: 13.58%
Risk
Beta: 1.08
Short Float: 0.03%
ROE: -0.20%
ROA: 0.02%